Jeil Pharma Holdings Inc

A002620

KR7002620003

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
10,670 ^KRW	-1.57%		-3.87%	-9.35%

2023	Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042.	CI

Jeil Pharma Holdings Inc's Equity Buyback announced on August 28, 2015, has expired.

August 24, 2017

The company expired its plan on August 25, 2017.

Latest news about Jeil Pharma Holdings Inc

Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042.	22-09-27	CI
Jeil Pharma Holdings Inc completed the acquisition of additional 35.2% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 250 billion.	18-11-15	CI
Jeil Pharma Holdings Inc made an offer to acquire an additional 47.6% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 490 billion.	18-10-01	CI
Jeil Pharma Holdings Inc(KOSE:A002620) dropped from S&P Global BMI Index	18-09-24	CI
Jeil Pharma Holdings Inc acquired 13.53% stake in Jeil Pharmaceutical Co.,Ltd.	18-05-01	CI
Jeil Pharma Holdings Inc(KOSE:A002620) dropped from KOSPI 200 Index	17-09-15	CI
Jeil Pharma Holdings Inc's Equity Buyback announced on August 28, 2015, has expired.	17-08-24	CI
Jeil Pharma Holdings Inc's Equity Buyback announced on November 7, 2013, has expired.	17-08-24	CI
Jeil Pharmaceutical Co., Ltd. announced the spin-off of its pharmaceuticals manufacturing and sales business.	17-01-15	CI
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 5, 2017.	16-11-03	CI
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till August 26, 2017.	16-08-25	CI
Jeil Pharmaceutical Co., Ltd.(KOSE:A002620) added to KOSPI 200 Index	16-06-10	CI
Tranche Update on Jeil Pharma Holdings Inc's Equity Buyback Plan announced on August 28, 2015.	15-11-26	CI
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 5, 2016.	15-11-05	CI
Jeil Pharma Holdings Inc announces an Equity Buyback for KRW 2,000 million worth of its shares.	15-08-27	CI
Jeil Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	15-08-27	CI
Jeil Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till November 7, 2013.	14-11-06	CI
Fidelity Management & Research Company and three related parties acquired 11.58% stake in Jeil Pharmaceutical Co., Ltd..	14-05-16	CI
Tranche Update on Jeil Pharma Holdings Inc's Equity Buyback Plan announced on November 7, 2013.	14-02-09	CI
Jeil Pharmaceutical Co., Ltd.’s Equity Buyback announced on January 31, 2013 has expired.	14-01-30	CI
Jeil Pharma Holdings Inc announces an Equity Buyback for KRW 2,000 million worth of its shares.	13-11-06	CI
Jeil Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	13-11-06	CI
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback in the amount of KRW2000 mm has expired	13-02-27	CI
Jeil Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	13-01-30	CI

Chart Jeil Pharma Holdings Inc

Duration

Period

More charts

JEIL PHARMA HOLDINGS INC., formerly Jeil Pharmaceutical Co.,Ltd is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, anticancer drugs, tristimania drugs, gastritis drugs, stomach ulcer drugs, septicemia treatments, pollakisuria treatments, acute bronchitis remedies, hyperlipidemia treatments and others. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
JEIL PHARMA HOLDINGS INC	-9.35%	120M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.08%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+17.48%	15.14B
CIPLA LIMITED	+13.18%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.57%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B

Generic Pharmaceuticals